HIF1A and neoplasm: In the 55 patients with stage III, G3 serous carcinomas, the overall survival of patients with tumours that stained strongly for HIF-1α differed significantly than that of patients with tumours that stained weakly or were negative for HIF-1α (p < 0.05).